Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical site injection for pain after orthopaedic trauma surgery
NCT03693404Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Dec 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection, morphine, ketorolac in lower extremity fracture, sponsored by NYU Langone Health. Started Dec 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionmorphineketorolac
03
Conditions
lower extremity fracture
Beyond the preview
Go deeper on NCT03693404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03693404.